Universal Biosensors appoints CEO Sharman and CFO Mullin to board; grants 25M options subject to approval

UNIVERSAL BIOSENSORS INC

Board expanded from 4 to 6 members; CEO John Sharman (Class II) and CFO Peter Mullin (Class I) appointed directors effective Jan 15, 2025.
Sharman granted 10M options: 5M at A$0.20 (2-yr vest) and 5M at A$0.30 (3-yr vest), subject to shareholder approval at 2025 AGM.
Mullin granted 15M options: 5M at A$0.15 (1-yr), 5M at A$0.20 (2-yr), 5M at A$0.30 (3-yr vest), also subject to shareholder approval.
Neither Sharman nor Mullin receives compensation for board service; only expense reimbursements.
Sharman and Mullin are not independent directors under SEC or Nasdaq rules.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John Sharman

Director

UNIVERSAL BIOSENSORS INC

Effective: 2025-01-15
Filed: January 15, 2025, 6:59 PM ET

On January 15, 2025, the board of directors (the “ Board ”) of Universal Biosensors, Inc. (the “ Company ”) increased the size of the Board from four to six members and appointed John Sharman, the Company’s Chief Executive Officer, and Peter Mullin, the Company’s Chief Financial Officer, to fill the newly created vacancy as Class II and Class I directors, respectively, effective immediately.

Appointed

Peter Mullin

Director

UNIVERSAL BIOSENSORS INC

Effective: 2025-01-15
Filed: January 15, 2025, 6:59 PM ET

On January 15, 2025, the board of directors (the “ Board ”) of Universal Biosensors, Inc. (the “ Company ”) increased the size of the Board from four to six members and appointed John Sharman, the Company’s Chief Executive Officer, and Peter Mullin, the Company’s Chief Financial Officer, to fill the newly created vacancy as Class II and Class I directors, respectively, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John Sharman was appointed as Director at UNIVERSAL BIOSENSORS INC.

Action: appointed
Role: Director

Exact text from the filing

On January 15, 2025, the board of directors (the “ Board ”) of Universal Biosensors, Inc. (the “ Company ”) increased the size of the Board from four to six members and appointed John Sharman, the Company’s Chief Executive Officer, and Peter Mullin, the Company’s Chief Financial Officer, to fill the newly created vacancy as Class II and Class I directors, respectively, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Peter Mullin was appointed as Director at UNIVERSAL BIOSENSORS INC.

Action: appointed
Role: Director

Exact text from the filing

On January 15, 2025, the board of directors (the “ Board ”) of Universal Biosensors, Inc. (the “ Company ”) increased the size of the Board from four to six members and appointed John Sharman, the Company’s Chief Executive Officer, and Peter Mullin, the Company’s Chief Financial Officer, to fill the newly created vacancy as Class II and Class I directors, respectively, effective immediately.

View on SEC.gov

Source: SEC EDGAR

accession 0001437749-25-001164

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.